Literature summary for 3.4.23.3 extracted from

Rao, C.M.; Scarborough, P.E.; Kay, J.; Batley, B.; Rapundalo, S.; Klutchko, S.; Taylor, M.D.; Lunney, E.A.; Humblet, C.C.; Dunn, B.M.
Specificity in the binding of inhibitors to the active site of human/primate aspartic proteinases: analysis of P2-P1-P1'-P2' variation (1993), J. Med. Chem., 36, 2614-2620.

Search for more literature for 3.4.23.3

Inhibitors

Inhibitors	Comment	Organism	Structure
N-(morpholine-4-sulfonyl)-L-phenylalanyl-N-[(2S,3S,5S)-1-cyclohexyl-3,5-dihydroxyheptan-2-yl]-N6-(methylcarbamothioyl)lysinamide	-	Homo sapiens
N-[(2S)-1-([(2S,3R,4S)-1-cyclohexyl-3,4-dihydroxy-6-methylheptan-2-yl]amino)-1-oxopent-4-en-2-yl]-Nalpha-(morpholine-4-sulfonyl)-L-phenylalaninamide	-	Homo sapiens
N-[(2S)-1-([(2S,3S,5S)-1-cyclohexyl-3,5-dihydroxy-6-methylheptan-2-yl]amino)-1-oxopent-4-en-2-yl]-Nalpha-(morpholine-4-sulfonyl)-L-phenylalaninamide	-	Homo sapiens

Organism

Organism	UniProt	Comment	Textmining
Homo sapiens	-	-	-

Use of this online version of BRENDA is free under the CC BY 4.0 license. See terms of use for full details.

Release 2023.1 (January 2023)